Health Care Policy

By Newt Gingrich: Trump’s plan is an impressive and thorough effort to fix the underlying dynamics in the pharmaceutical marketplace.

By Michael Tanner: While the mandate was always the most unpopular part, it was never the structural heart of the Affordable Care Act.

By Charles Blahous: Obamacare had the predictable effect of increasing not only federal but national health spending.

By Raymond J. March: Biotech and pharmaceutical companies can and do cure diseases; it’s government intervention that causes problems.

By Marie Fishpaw and Grace-Marie Turner: Americans need genuine relief that doesn’t just paper over Obamacare’s serious flaws, but instead opens a new path for real reform.

By Christopher Jacobs: I thought Paul Ryan had a plan, and that achieving consensus on a plan would prove the tough part. But Ryan didn’t even have a plan.

By Aparna Mathur: It has been claimed that more than 50 percent of all bankruptcy filings in the U.S. were caused by medical debts.

By Mark J. Perry: Hint: it’s because of competitive markets.

By Tim Rice: Developments have given us a glimpse of a better health care system that emphasizes competition, price transparency, and patient autonomy.

By Robert Moffit: Another congressional spending binge is not likely to “stabilize” Obamacare’s insurance markets or “reduce” enrollees’ premiums.  

By Sens. Ted Cruz & Mike Lee, Reps. Mark Meadows & Jim Jordan: We are closer than ever to sending ObamaCare to the ash heap of history.

By Christopher Jacobs: The study itself admits that most of the supposed premium “reduction” for 2019 likely will not materialize.